Health Sciences
Mathieu Latour
- Professeur agrégé de clinique
-
Faculté de médecine - Département de pathologie et biologie cellulaire
Secondary numbers:
514 890-8000 #36217
(Travail 1)
514 412-7396
(Télécopieur)
Secondary email:
mathieu.latour.chum@ssss.gouv.qc.ca
(Travail)
Profile
Research expertise
Thèmes
- Pathologie rénale
- Urologique
- Surrénalienne
Intérêts de recherche
- Cancer de la prostate
- Cancer de la vessie
- Cancer du rein
- Transplantation rénale
- Inflammation rénale
- Fibrose
Awards and recognitions
- Prix Esculape (2011)
Affiliations and responsabilities
Research affiliations
Research units
Membre
Affiliated institutions
- Centre hospitalier de l’Université de Montréal (CHUM)
Teaching and supervision
Projects
Research projects
2020
- 2026
Diagnosis of Aggressive Prostate Cancer Using Key Features of Raman Spectroscopy
Lead researcher :
Dominique Trudel
Co-researchers :
Fred Saad
,
Pierre Chaurand
,
Mathieu Latour
,
Roula Albadine
,
Frédéric Leblond
,
Mathieu Lavallée-Adam
,
Sangeeta Murugkar
Funding sources:
IRSC/Instituts de recherche en santé du Canada
Grant programs:
PVXXXXXX-(PJT) Subvention Projet
2017
- 2022
Effets de l'infiltration de leucocytes dans le carcinome intracanaliculaire de la prostate
Lead researcher :
Dominique Trudel
Co-researchers :
Fred Saad
,
Réjean Lapointe
,
Mathieu Latour
,
Roula Albadine
,
Yves Fradet
,
Alain Bergeron
Funding sources:
IRSC/Instituts de recherche en santé du Canada
,
SRC/Société de recherche sur le cancer
Grant programs:
PVXX5647-(MOP) Subvention de fonctionnement incluant les subventions de fonctionnement programmatiques (général)
,
2017
- 2020
Effects of the leucocytic infiltration of intraductal carcinoma of the prostate
Lead researcher :
Dominique Trudel
Co-researchers :
Fred Saad
,
Réjean Lapointe
,
Mathieu Latour
,
Roula Albadine
,
Yves Fradet
,
Alain Bergeron
Outreach
Autres activités et contributions
- Directeur du programme de résidence en anatomopathologie de 2012 à 2016
Publications and presentations
Publications
- Lavigueur-Blouin H, Noriega AC, Valdivieso R, Hueber PA, Bienz M, Alhathal N, Latour M, Trinh QD, El-Hakim A, Zorn KC. Predictors of early continence following robot-assisted radical prostatectomy. Can Urol Assoc J. 2015 Jan-Feb;9(1-2).
- Blume-Jensen P, Berman DM, Rimm DL, Shipitsin M, Putzi M, Nifong TP, Small C, Choudhury S, Capela T, Coupal L, Ernst C, Hurley A, Kaprelyants A, Chang H, Giladi E, Nardone J, Dunyak J, Loda M, Klein EA, Magi-Galluzzi C, Latour M, Epstein JI, Kantoff P, Saad F.Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancer. Clin Cancer Res. 2015 Jun 1;21(11):2591-600.
- Bienz M, Hueber PA, Trudeau V, Alenizi AM, Valdivieso R, Alom M, Balbay MD, Canda AE, Mouraviev V, Albala DM, El-Hakim A, Trinh QD, Latour M, Saad F, Zorn KC. Prevalence and risk factors of contralateral extraprostatic extension in men undergoing radical prostatectomy for unilateral disease at biopsy: A global multi-institutional experience.Can Urol Assoc J. 2015 Jul-Aug;9(7-8):E434-8.
- Cancer Genome Atlas Research Network (Collaborators 312).The Molecular Taxonomy of Primary Prostate Cancer.Cell. 2015 Nov 5;163(4):1011-25.
- Ghorayeb NE, Rondeau G, Latour M, Cohade C, Olney H, Lacroix A, Perrotte P, Sabourin A, Mazzuco TL, Bourdeau I.Rapid and Complete Remission of Metastatic Adrenocortical Carcinoma Persisting 10 Years After Treatment With Mitotane Monotherapy: Case Report and Review of the Literature.Medicine (Baltimore). 2016 Mar;95(13)